Found 0 matching trials
SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
PHASE3The primary objective of the study is to demonstrate the efficacy of SPD489...
Location
Radiant Research, Inc.
SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder
PHASE2To evaluate the efficacy of SPD489 for the treatment of executive function ...
Location
Sun Valley Research Center
A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users
PHASE1This single-center study will be a single-dose, randomized, double-blind, p...
Location
Vince and Associates Clinical Research, Inc.
Pharmacokinetics of Lisdexamfetamine (Vyvanse®) in Post-bariatric Surgery Patients
PHASE4This study is being conducted to evaluate how the body absorbs and processe...
Location
Neuropsychiatric Research Institute
Stimulant Effects on Disruptive Behavior
PHASE4The goal of this study is to determine the effects of stimulant medication ...
Location
University of Iowa Hospitals and Clinics
Attention & Memory Impairments in Menopausal Women
PHASE4The purpose of this study is to determine whether a medication called Vyvan...
Location
Penn Center for Women's Behavioral Wellness
Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)
PHASE2This study will test the effectiveness of lisdexamfetamine medication as a ...
Location
Yale School of Medicine
Drug Use Study With VYVANSE® in Australia for Binge Eating Disorder
N/AThis study will check how and to whom Vyvanse is prescribed in Australia by...
Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17
PHASE3The main aim of this study is to see if giving LDX to children and adolesce...
Location
ZiekenhuisNetwerk Antwerpen, Commandant Weynsstraat 165, Campus Hoge Beuken
Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia
PHASE1This is a multiple ascending dose study; the purpose of this study is to ex...
Location
California Clinical Trials